Stockreport

Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulatory Status of its CRISPR Genome-Edited C3007 Trait in Camelina, Paving the Way for U.S. Field Tests

YIELD10 BISCIENCE INC NEW  (YTEN) 
US:NASDAQ Investor Relations: ir.yield10bio.com/investor-relations
PDF WOBURN, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a po [Read more]